コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ortem and HD mouse striata, correlating with neuronal death.
2 ation has been previously linked to ischemic neuronal death.
3 rlying cause of the CerS1 deficiency-induced neuronal death.
4 um responses, calcium overload and increased neuronal death.
5 rs attenuated misfolded tau accumulation and neuronal death.
6 f blood-retina barrier breakdown, edema, and neuronal death.
7 phagy, which are known to mediate poststroke neuronal death.
8 avage limit mitochondrial fusion and promote neuronal death.
9 ndent transcriptional activity, and promotes neuronal death.
10 ns did not show any signs of inflammation or neuronal death.
11 equally resistant to proneurotrophin-induced neuronal death.
12 s of photoreceptors was used as a measure of neuronal death.
13 f blood-retina barrier breakdown, edema, and neuronal death.
14 ameliorate symptoms, but not the underlying neuronal death.
15 ytokines may play a direct role in promoting neuronal death.
16 nal superoxide signal, oxidative stress, and neuronal death.
17 eurotransmitter release, and ultimately with neuronal death.
18 cal role for non-NMDA glutamate receptors in neuronal death.
19 in pathological events leading ultimately to neuronal death.
20 inner membrane depolarization, and apoptotic neuronal death.
21 by oligodendrocyte damage, demyelination and neuronal death.
22 tween AEME and mAChRs and how it can lead to neuronal death.
23 ionic homoeostasis, resulting in axonal and neuronal death.
24 at PD is caused by irreversible dopaminergic neuronal death.
25 from synaptic clefts to prevent excitotoxic neuronal death.
26 erminal Set-beta cleavage product can induce neuronal death.
27 ogical hallmark of HD, but did not influence neuronal death.
28 successfully identify new mechanisms driving neuronal death.
29 ("excitotoxicity") induces acute or delayed neuronal death.
30 s, re-entry into the cell-cycle and eventual neuronal death.
31 to ER stress and provides protection against neuronal death.
32 ed to be the main cause for ischemia-induced neuronal death.
33 ial protein import causes mutant Htt-induced neuronal death.
34 (NTR), resulting in axonal fragmentation and neuronal death.
35 , synaptic dysfunction, neuronal injury, and neuronal death.
36 CK1 is causally related to ischemia-induced neuronal death.
37 (d) to identify RNAi knockdowns that enhance neuronal death.
38 vation of extrasynaptic NMDARs, and ischemic neuronal death.
39 er's disease brain, possibly contributing to neuronal death.
40 s, and astrocyte conditioned media triggered neuronal death.
41 t nodose ganglia following capsaicin-induced neuronal death.
42 lin homolog NRA-2 enhances MEC-10(d)-induced neuronal death.
43 d robust protection against ischemia-induced neuronal death.
44 and causes only minimal demyelination and no neuronal death.
45 equently leading to synaptic dysfunction and neuronal death.
46 plasmic reticulum, influencing the extent of neuronal death.
47 tate of neurons, may be critical in ischemic neuronal death.
48 ork function, which contribute to subsequent neuronal death.
49 revents miR-29c down-regulation and ischemic neuronal death.
50 ld lead to early metabolic failure promoting neuronal death.
51 /calpain-2 in CNS function in plasticity and neuronal death.
52 ccompanied by microtubule destabilization or neuronal death.
53 t it played a major role in calpain-mediated neuronal death.
54 n the cells of the brain ultimately provokes neuronal death.
55 particular their role in glutamate-mediated neuronal death.
56 ched protein tyrosine phosphatase (STEP) and neuronal death.
57 in mitochondrial morphology in p53-dependent neuronal death.
58 hen targets the dopaminergic neurons causing neuronal death.
59 changes, such as hyperphosphorylated tau and neuronal death.
60 ta causes neuronal dysfunction and may drive neuronal death.
61 g, activates signaling cascades that lead to neuronal death.
62 o the disruption of cellular homeostasis and neuronal death.
63 egates and the loss of cellular function and neuronal death.
64 rative conditions and a major contributor to neuronal death.
65 -mediated neuroinflammation, thus increasing neuronal death.
66 axonal degeneration in the absence of overt neuronal death.
67 he underlying mechanisms responsible for the neuronal death.
68 rized by increased microglial activation and neuronal death.
69 in this context, it also reduces SE-induced neuronal death.
70 than mere cellular debris produced following neuronal death.
71 icative of axonal dieback that progresses to neuronal death.
72 -methyl-4-phenyl pyrinidium (MPP(+))-induced neuronal death.
73 urons in vivo, strongly enhances excitotoxic neuronal death.
74 known to penetrate into the brain and cause neuronal death.
75 rategy for the treatment of delayed ischemic neuronal death.
76 lain why the former but not the latter cause neuronal death.
77 t compression of the injured spinal cord and neuronal death.
78 dult guts, given previous reports of ongoing neuronal death.
79 dysfunction, tau accumulation, and eventual neuronal death.
80 ns numerous inclusions, there is very little neuronal death.
82 300 mg/kg significantly reduced hippocampal neuronal death after brain ischemia, inhibited the ische
83 eimer disease, cleavage of Set-beta leads to neuronal death after stroke, and the full-length Set-bet
84 ignificantly mitigates mHTT accumulation and neuronal death, ameliorating disease-associated phenotyp
85 ws: the cytokine induced caspase-independent neuronal death and accelerated autophagic flux in BDNF-t
86 tinamide salvage, both NAD(+) and NR prevent neuronal death and AxD in a manner that depends on inter
89 tosis of NPCs, ZIKV infection causes massive neuronal death and axonal rarefaction, which phenocopy f
95 ural inflammation; these pathologies lead to neuronal death and consequently clinical symptoms, such
96 -associated protein tau, which are linked to neuronal death and disease development and can be caused
98 V (MEX1-44), DENV2 grows slower, causes less neuronal death and fails to cause postnatal animal death
100 CD38 deletion and NAD(+) supplementation on neuronal death and glial activation in the facial nucleu
101 t hypoxia followed by re-oxygenation lead to neuronal death and hallmarks of an injury response, incl
102 Whether axonal p75 signaling contributes to neuronal death and how signaling endosomes contribute to
109 vivo models of cerebral ischemia, decreasing neuronal death and reducing infarct size, allowing us to
110 epilepticus (SRSE) have been shown to cause neuronal death and reorganization, and visual inspection
113 nactivation underlies excitotoxicity-induced neuronal death and suggest that PKD1 inactivation may be
114 equirement for DNMTs in mutant Htt-triggered neuronal death and suggesting a neurodegenerative mechan
116 buffering and temporally preceded apoptotic neuronal death and the generation of spontaneous seizure
117 le for PTPsigma (and LAR) in both retrograde neuronal death and the poor intrinsic regenerative abili
121 is a controlled process that may not lead to neuronal death and, thus, we term this phenomenon "neuri
123 membralin results in beta-amyloid pathology, neuronal death, and exacerbates synaptic/memory deficits
125 OSU-0212320 substantially reduced mortality, neuronal death, and spontaneous recurrent seizures in a
127 r mechanisms whereby HDAC inhibitors prevent neuronal death are currently the focus of intensive rese
128 oss, degeneration of neuronal processes, and neuronal death are hallmarks of neurological diseases an
129 ese results suggest that factors that induce neuronal death are likely to be necessary to initiate th
130 totoxic activation of p38MAPK and subsequent neuronal death are reduced by competing with the nNOS:NO
131 REST-dependent repression of miR-132 in the neuronal death associated with global ischemia and ident
133 trocytes causes glial activation, tauopathy, neuronal death, brain atrophy, cognitive impairment and
135 I) at preterm gestation that is unrelated to neuronal death but is associated with decreased dendriti
136 ation causes initial axonal degeneration and neuronal death but subsequent axon outgrowth from surviv
137 eurogenesis is not limited to injury-induced neuronal death, but also can result from normally occurr
138 Tauopathy is accompanied by significant neuronal death, but the relationships between initial ta
141 by overactivation of calpains, which induce neuronal death by catalyzing limited proteolysis of spec
143 pport that temperature increase worsened the neuronal death by depleting intracellular ATP, inducing
149 nd ischemia and that increased apoptosis and neuronal death contribute to the risks to ID in humans.
150 rib3 overexpression is sufficient to promote neuronal death; conversely, Trib3 knockdown protects neu
151 n blood flow is restored, and causes delayed neuronal death (DND) in selective vulnerable regions.
155 ath, E2F4 plays a crucial protective role in neuronal death evoked by DNA damage, hypoxia, and global
156 ia exhibited an increased capacity to induce neuronal death ex vivo and in vivo in the presence of st
157 e pharmacologic inhibition of ASIC1a reduces neuronal death following ischemic stroke in rodents.
159 CaN-mediated Drp1 dephosphorylation promotes neuronal death following oxygen-glucose deprivation.
163 ynuclein (alpha-syn) leading to dopaminergic neuronal death has been recognized as one of the main pa
164 e connection between respiratory defects and neuronal death has never been proven, this hypothesis ha
165 roposed to be a central mechanism leading to neuronal death in a range of neurodegenerative diseases.
166 levels associated with plaque deposition and neuronal death in a transgenic mouse model of cerebral b
167 ate excitotoxicity, which is accountable for neuronal death in acute neurological disorders, includin
169 xidative stress and subsequent DNA damage to neuronal death in Alzheimer's disease and related tauopa
172 g promotes relaxation of heterochromatin and neuronal death in an in vivo model of neurodegenerative
176 l source protected against glutamate-induced neuronal death in control, but not ARALAR-deficient neur
178 thies and identifies a new pathway mediating neuronal death in currently untreatable human neurodegen
183 tivity caused by OGD/ischemia contributes to neuronal death in hippocampal neurons via diverse effect
184 key role in a variety of diseases, including neuronal death in ischemia, cancer, cardiac atrial fibri
186 1 prevented AbetaO-induced synaptic loss and neuronal death in mouse cultured neurons and long-term p
192 ally in animals causes selective and delayed neuronal death in pyramidal neurons of the hippocampal C
194 75 neurotrophin receptor (p75(NTR)) mediates neuronal death in response to neural insults by activati
196 (ischemic preconditioning or IPC) can reduce neuronal death in response to subsequent severe ischemic
198 r pathways, leading to neuroinflammation and neuronal death in specific brain regions resulting in se
199 Twelve hours of mild hypothermia attenuated neuronal death in subiculum and thalamus but not CA1 and
201 ng global cerebral ischemia, exhibit greater neuronal death in the CA1 area of the hippocampus and re
204 ult rats, oral treatment with EVT901 reduced neuronal death in the hippocampus and thalamus, reduced
206 rom this protein by MHC-I, which triggers DA neuronal death in the presence of appropriate cytotoxic
208 and moderate susceptibility to WNV-mediated neuronal death in Tlr8(-/-) mice were attributed to over
210 ficiency did not aggravate glutamate-induced neuronal death in vitro, although glutamate-stimulated r
212 tivation of Akt protects against hippocampal neuronal death in vivo following status epilepticus.
213 hil infiltration, ischemic brain damage, and neuronal death in vivo using an adenovirus encoding a re
215 ARM1 ortholog TIR-1 leads to NAD(+) loss and neuronal death, indicating these activities are an evolu
218 hagy plays a significant role in hippocampal neuronal death induced by cerebral I/R following asphyxi
219 rations in overall protein synthesis precede neuronal death induced by deprivation of excitatory affe
223 europrotective profile on in vitro models of neuronal death induced by oxidative stress and energy de
224 We conclude that, both in vitro and in vivo, neuronal death induced by p75(NTR) requires the DD and T
226 g by disulfide-linked dimers of p75(NTR) for neuronal death induced by proneurotrophins and epileptic
230 n particular cyclin D/Cdk4, is implicated in neuronal death induced by various pathologic stresses, i
233 Neuritic retraction in the absence of overt neuronal death is a shared feature of normal aging and n
241 e that is expressed by Muller glia following neuronal death, is required for Muller glia to progress
242 esults indicate a role for Cdc25A in delayed neuronal death mediated by ischemia.SIGNIFICANCE STATEME
243 ing ischaemia nearly completely prevents the neuronal death, microglial inflammation and sensorimotor
244 -mediated ribosomal stress may contribute to neuronal death, neurodevelopmental disruption and microc
245 the nucleolus may trigger the p53-dependent neuronal death, neurotoxic consequences of a selective i
246 NK) signaling pathway is a critical step for neuronal death occurring in several neurological conditi
248 een shown to contribute to ethanol-activated neuronal death of the stress regulatory proopiomelanocor
252 gy, XJB-5-131 promotes weight gain, prevents neuronal death, reduces oxidative damage in neurons, sup
255 n are impaired, and synaptic dysfunction and neuronal death result, with ensuing thinning of key brai
257 characterized by progressive dysfunction and neuronal death, showing specific protein inclusions at a
259 ome-mediated, ethanol-induced beta-endorphin neuronal death.SIGNIFICANCE STATEMENT Neurotoxic action
260 onist activates survival signals and reduces neuronal death significantly better than GDNF, suggestin
261 While strain magnitude affects the time of neuronal death, strain rate influences the pathomorpholo
262 tosis proteins or proteasome function led to neuronal death, suggesting that caspase activation is sp
263 ons (2-4% DMSO) induce caspase-3 independent neuronal death that involves apoptosis-inducing factor (
264 gger death of naive neurons and to propagate neuronal death through activation of naive astrocytes to
268 ects against stroke-induced brain injury and neuronal death through pharmacological regulation of ion
269 cine protects against excitotoxicity-induced neuronal death through the non-ionotropic activity of Gl
270 , an excessive release of glutamate triggers neuronal death through the overactivation of NMDA recept
271 eases such as multiple sclerosis may lead to neuronal death, thus causing irreversible functional imp
272 ken up by axons and induce axonotoxicity and neuronal death, thus recapitulating key neuropathologica
274 with calpain activation and is the result of neuronal death triggered by brain-infiltrating inflammat
275 re significantly increased at D1 and D7, and neuronal death (TUNEL+ / NeuN+ cells) and BBB permeabili
276 rvations have implications for mechanisms of neuronal death under conditions of reduced glucose and m
277 xpression changes induced by AP5, and led to neuronal death under long-term tetrodotoxin or AP5 treat
278 es slightly shorter than those causing acute neuronal death; under these conditions, cytosolic Zn(2+)
287 re the role of the truncated Src fragment in neuronal death, we expressed a recombinant truncated Src
288 d mitochondrial import defect and subsequent neuronal death were attenuated by overexpression of TIM2
289 amyloid precursor protein, synaptic loss and neuronal death were driven by ERK-activated microglia an
290 , the activity of pro-apoptotic caspases and neuronal death were enhanced in prion-infected SARM1 (-/
292 rons, NMDA-induced superoxide production and neuronal death were prevented by intracellular acidifica
294 ated with bim gene activation and subsequent neuronal death, whereas enhanced Hsp27 expression preven
295 d decreased mTORC1 signaling which increased neuronal death, whereas ISR activation was neuroprotecti
296 eramide-1-phosphate or A23187 induced spinal neuronal death, which was substantially reversed by arac
297 ellular release of misfolded tau followed by neuronal death, which we confirmed by correction of the
298 in the absence of hallmark viral budding or neuronal death, with transmission occurring efficiently
299 athways that result in WNV-induced apoptotic neuronal death within the CNS have not been established.